Effectiveness and safety of modified fully oral 9-month treatment regimens for rifampicin-resistant tuberculosis: a prospective cohort studyOleksandr Korotych, Askar Yedilbayev, Alena Skrahina et al.|The Lancet Infectious Diseases|2024Cited by 23
Tuberculosis Co-Infection Is Common in Patients Requiring Hospitalization for COVID-19 in Belarus: Mixed-Methods StudyYuliia Sereda, Alena Skrahina, Oleksandr Korotych et al.|International Journal of Environmental Research and Public Health|2022Cited by 12
Factors Associated with Unfavourable Treatment Outcomes in Patients with Tuberculosis: A 16-Year Cohort Study (2005–2020), Republic of Karakalpakstan, UzbekistanJamshid Gadoev, Masoud Dara, Damin Asadov et al.|International Journal of Environmental Research and Public Health|2021Cited by 9